1 Study Coverage 1.1 HPV Associated Disorder Revenue in HPV Associated Disorder Business (2017-2022) & (US$ Million) Introduction 1.2 Global HPV Associated Disorder Outlook 2017 VS 2022 VS 2028 1.2.1 Global HPV Associated Disorder Market Size for the Year 2017-2028 1.2.2 Global HPV Associated Disorder Market Size for the Year 2017-2028 1.3 HPV Associated Disorder Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States HPV Associated Disorder in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of HPV Associated Disorder Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 HPV Associated Disorder Market Dynamics 1.4.1 HPV Associated Disorder Industry Trends 1.4.2 HPV Associated Disorder Market Drivers 1.4.3 HPV Associated Disorder Market Challenges 1.4.4 HPV Associated Disorder Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 HPV Associated Disorder by Type 2.1 HPV Associated Disorder Market Segment by Type 2.1.1 Prevention 2.1.2 Treatment 2.2 Global HPV Associated Disorder Market Size by Type (2017, 2022 & 2028) 2.3 Global HPV Associated Disorder Market Size by Type (2017-2028) 2.4 United States HPV Associated Disorder Market Size by Type (2017, 2022 & 2028) 2.5 United States HPV Associated Disorder Market Size by Type (2017-2028) 3 HPV Associated Disorder by Application 3.1 HPV Associated Disorder Market Segment by Application 3.1.1 Hospital Pharmacies 3.1.2 Retail Pharmacies 3.1.3 Online Pharmacies 3.2 Global HPV Associated Disorder Market Size by Application (2017, 2022 & 2028) 3.3 Global HPV Associated Disorder Market Size by Application (2017-2028) 3.4 United States HPV Associated Disorder Market Size by Application (2017, 2022 & 2028) 3.5 United States HPV Associated Disorder Market Size by Application (2017-2028) 4 Global HPV Associated Disorder Competitor Landscape by Company 4.1 Global HPV Associated Disorder Market Size by Company 4.1.1 Top Global HPV Associated Disorder Companies Ranked by Revenue (2021) 4.1.2 Global HPV Associated Disorder Revenue by Player (2017-2022) 4.2 Global HPV Associated Disorder Concentration Ratio (CR) 4.2.1 HPV Associated Disorder Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of HPV Associated Disorder in 2021 4.2.3 Global HPV Associated Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global HPV Associated Disorder Headquarters, Revenue in HPV Associated Disorder Business (2017-2022) & (US$ Million) Type 4.3.1 Global HPV Associated Disorder Headquarters and Area Served 4.3.2 Global HPV Associated Disorder Companies Revenue in HPV Associated Disorder Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into HPV Associated Disorder Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States HPV Associated Disorder Market Size by Company 4.5.1 Top HPV Associated Disorder Players in United States, Ranked by Revenue (2021) 4.5.2 United States HPV Associated Disorder Revenue by Players (2020, 2021 & 2022) 5 Global HPV Associated Disorder Market Size by Region 5.1 Global HPV Associated Disorder Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global HPV Associated Disorder Market Size by Region (2017-2028) 5.2.1 Global HPV Associated Disorder Market Size by Region: 2017-2022 5.2.2 Global HPV Associated Disorder Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America HPV Associated Disorder Market Size YoY Growth 2017-2028 6.1.2 North America HPV Associated Disorder Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific HPV Associated Disorder Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific HPV Associated Disorder Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe HPV Associated Disorder Market Size YoY Growth 2017-2028 6.3.2 Europe HPV Associated Disorder Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America HPV Associated Disorder Market Size YoY Growth 2017-2028 6.4.2 Latin America HPV Associated Disorder Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa HPV Associated Disorder Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa HPV Associated Disorder Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Merck & Co., Inc 7.1.1 Merck & Co., Inc Company Details 7.1.2 Merck & Co., Inc Business Overview 7.1.3 Merck & Co., Inc HPV Associated Disorder Introduction 7.1.4 Merck & Co., Inc Revenue in HPV Associated Disorder Business (2017-2022) 7.1.5 Merck & Co., Inc Recent Development 7.2 GlaxoSmithKline plc 7.2.1 GlaxoSmithKline plc Company Details 7.2.2 GlaxoSmithKline plc Business Overview 7.2.3 GlaxoSmithKline plc HPV Associated Disorder Introduction 7.2.4 GlaxoSmithKline plc Revenue in HPV Associated Disorder Business (2017-2022) 7.2.5 GlaxoSmithKline plc Recent Development 7.3 F. Hoffmann-La Roche Ltd 7.3.1 F. Hoffmann-La Roche Ltd Company Details 7.3.2 F. Hoffmann-La Roche Ltd Business Overview 7.3.3 F. Hoffmann-La Roche Ltd HPV Associated Disorder Introduction 7.3.4 F. Hoffmann-La Roche Ltd Revenue in HPV Associated Disorder Business (2017-2022) 7.3.5 F. Hoffmann-La Roche Ltd Recent Development 7.4 Pfizer, Inc. 7.4.1 Pfizer, Inc. Company Details 7.4.2 Pfizer, Inc. Business Overview 7.4.3 Pfizer, Inc. HPV Associated Disorder Introduction 7.4.4 Pfizer, Inc. Revenue in HPV Associated Disorder Business (2017-2022) 7.4.5 Pfizer, Inc. Recent Development 7.5 Allergan plc 7.5.1 Allergan plc Company Details 7.5.2 Allergan plc Business Overview 7.5.3 Allergan plc HPV Associated Disorder Introduction 7.5.4 Allergan plc Revenue in HPV Associated Disorder Business (2017-2022) 7.5.5 Allergan plc Recent Development 7.6 AstraZeneca plc 7.6.1 AstraZeneca plc Company Details 7.6.2 AstraZeneca plc Business Overview 7.6.3 AstraZeneca plc HPV Associated Disorder Introduction 7.6.4 AstraZeneca plc Revenue in HPV Associated Disorder Business (2017-2022) 7.6.5 AstraZeneca plc Recent Development 7.7 Biocon Ltd 7.7.1 Biocon Ltd Company Details 7.7.2 Biocon Ltd Business Overview 7.7.3 Biocon Ltd HPV Associated Disorder Introduction 7.7.4 Biocon Ltd Revenue in HPV Associated Disorder Business (2017-2022) 7.7.5 Biocon Ltd Recent Development 7.8 Eli Lilly and Company 7.8.1 Eli Lilly and Company Company Details 7.8.2 Eli Lilly and Company Business Overview 7.8.3 Eli Lilly and Company HPV Associated Disorder Introduction 7.8.4 Eli Lilly and Company Revenue in HPV Associated Disorder Business (2017-2022) 7.8.5 Eli Lilly and Company Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. HPV Associated Disorder Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. HPV Associated Disorder Market Trends Table 3. HPV Associated Disorder Market Drivers Table 4. HPV Associated Disorder Market Challenges Table 5. HPV Associated Disorder Market Restraints Table 6. Global HPV Associated Disorder Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States HPV Associated Disorder Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global HPV Associated Disorder Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States HPV Associated Disorder Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top HPV Associated Disorder Companies in Global Market, Ranking by Revenue (2021) Table 11. Global HPV Associated Disorder Revenue by Player, (US$ Million), 2017-2022 Table 12. Global HPV Associated Disorder Revenue Share by Player, 2017-2022 Table 13. Global HPV Associated Disorder Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global HPV Associated Disorder by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HPV Associated Disorder as of 2021) Table 15. Top Players of HPV Associated Disorder in Global Market, Headquarters and Area Served Table 16. Companies Revenue in HPV Associated Disorder Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into HPV Associated Disorder Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top HPV Associated Disorder Players in United States Market, Ranking by Revenue (2021) Table 20. United States HPV Associated Disorder Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States HPV Associated Disorder Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global HPV Associated Disorder Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global HPV Associated Disorder Market Size by Region (2017-2022) & (US$ Million) Table 24. Global HPV Associated Disorder Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America HPV Associated Disorder Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific HPV Associated Disorder Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe HPV Associated Disorder Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa HPV Associated Disorder Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa HPV Associated Disorder Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Merck & Co., Inc Company Details Table 31. Merck & Co., Inc Business Overview Table 32. Merck & Co., Inc HPV Associated Disorder Product Table 33. Merck & Co., Inc Revenue in HPV Associated Disorder Business (2017-2022) & (US$ Million) Table 34. Merck & Co., Inc Recent Development Table 35. GlaxoSmithKline plc Company Details Table 36. GlaxoSmithKline plc Business Overview Table 37. GlaxoSmithKline plc HPV Associated Disorder Product Table 38. GlaxoSmithKline plc Revenue in HPV Associated Disorder Business (2017-2022) & (US$ Million) Table 39. GlaxoSmithKline plc Recent Development Table 40. F. Hoffmann-La Roche Ltd Company Details Table 41. F. Hoffmann-La Roche Ltd Business Overview Table 42. F. Hoffmann-La Roche Ltd HPV Associated Disorder Product Table 43. F. Hoffmann-La Roche Ltd Revenue in HPV Associated Disorder Business (2017-2022) & (US$ Million) Table 44. F. Hoffmann-La Roche Ltd Recent Development Table 45. Pfizer, Inc. Company Details Table 46. Pfizer, Inc. Business Overview Table 47. Pfizer, Inc. HPV Associated Disorder Product Table 48. Pfizer, Inc. Revenue in HPV Associated Disorder Business (2017-2022) & (US$ Million) Table 49. Pfizer, Inc. Recent Development Table 50. Allergan plc Company Details Table 51. Allergan plc Business Overview Table 52. Allergan plc HPV Associated Disorder Product Table 53. Allergan plc Revenue in HPV Associated Disorder Business (2017-2022) & (US$ Million) Table 54. Allergan plc Recent Development Table 55. AstraZeneca plc Company Details Table 56. AstraZeneca plc Business Overview Table 57. AstraZeneca plc HPV Associated Disorder Product Table 58. AstraZeneca plc Revenue in HPV Associated Disorder Business (2017-2022) & (US$ Million) Table 59. AstraZeneca plc Recent Development Table 60. Biocon Ltd Company Details Table 61. Biocon Ltd Business Overview Table 62. Biocon Ltd HPV Associated Disorder Product Table 63. Biocon Ltd Revenue in HPV Associated Disorder Business (2017-2022) & (US$ Million) Table 64. Biocon Ltd Recent Development Table 65. Eli Lilly and Company Company Details Table 66. Eli Lilly and Company Business Overview Table 67. Eli Lilly and Company HPV Associated Disorder Product Table 68. Eli Lilly and Company Revenue in HPV Associated Disorder Business (2017-2022) & (US$ Million) Table 69. Eli Lilly and Company Recent Development Table 70. Research Programs/Design for This Report Table 71. Key Data Information from Secondary Sources Table 72. Key Data Information from Primary Sources List of Figures Figure 1. HPV Associated Disorder Product Picture Figure 2. Global HPV Associated Disorder Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global HPV Associated Disorder Market Size 2017-2028 (US$ Million) Figure 4. United States HPV Associated Disorder Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States HPV Associated Disorder Market Size 2017-2028 (US$ Million) Figure 6. United States HPV Associated Disorder Market Share in Global 2017-2028 Figure 7. HPV Associated Disorder Report Years Considered Figure 8. Product Picture of Prevention Figure 9. Product Picture of Treatment Figure 10. Global HPV Associated Disorder Market Share by Type in 2022 & 2028 Figure 11. Global HPV Associated Disorder Market Size by Type (2017-2028) & (US$ Million) Figure 12. Global HPV Associated Disorder Market Share by Type (2017-2028) Figure 13. United States HPV Associated Disorder Market Share by Type in 2022 & 2028 Figure 14. United States HPV Associated Disorder Market Size by Type (2017-2028) & (US$ Million) Figure 15. United States HPV Associated Disorder Market Share by Type (2017-2028) Figure 16. Product Picture of Hospital Pharmacies Figure 17. Product Picture of Retail Pharmacies Figure 18. Product Picture of Online Pharmacies Figure 19. Global HPV Associated Disorder Market Share by Application in 2022 & 2028 Figure 20. Global HPV Associated Disorder Market Size by Application (2017-2028) & (US$ Million) Figure 21. Global HPV Associated Disorder Market Share by Application (2017-2028) Figure 22. United States HPV Associated Disorder Market Share by Application in 2022 & 2028 Figure 23. United States HPV Associated Disorder Market Size by Application (2017-2028) & (US$ Million) Figure 24. United States HPV Associated Disorder Market Share by Application (2017-2028) Figure 25. North America HPV Associated Disorder Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. U.S. HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe HPV Associated Disorder Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific HPV Associated Disorder Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Taiwan HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Philippines HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Latin America HPV Associated Disorder Market Size Growth Rate 2017-2028 (US$ Million) Figure 46. Mexico HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Brazil HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Argentina HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Middle East & Africa HPV Associated Disorder Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Turkey HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Saudi Arabia HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. U.A.E HPV Associated Disorder Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Merck & Co., Inc Revenue Growth Rate in HPV Associated Disorder Business (2017-2022) Figure 54. GlaxoSmithKline plc Revenue Growth Rate in HPV Associated Disorder Business (2017-2022) Figure 55. F. Hoffmann-La Roche Ltd Revenue Growth Rate in HPV Associated Disorder Business (2017-2022) Figure 56. Pfizer, Inc. Revenue Growth Rate in HPV Associated Disorder Business (2017-2022) Figure 57. Allergan plc Revenue Growth Rate in HPV Associated Disorder Business (2017-2022) Figure 58. AstraZeneca plc Revenue Growth Rate in HPV Associated Disorder Business (2017-2022) Figure 59. Biocon Ltd Revenue Growth Rate in HPV Associated Disorder Business (2017-2022) Figure 60. Eli Lilly and Company Revenue Growth Rate in HPV Associated Disorder Business (2017-2022) Figure 61. Bottom-up and Top-down Approaches for This Report Figure 62. Data Triangulation Figure 63. Key Executives Interviewed

Merck & Co., Inc GlaxoSmithKline plc F. Hoffmann-La Roche Ltd Pfizer, Inc. Allergan plc AstraZeneca plc Biocon Ltd Eli Lilly and Company